APEIRON Biologics competitors and similar companiesClear all

APEIRON Biologics's competitors and similar companies include OxThera, KBP Biosciences, Abivax and Siege Pharmaceuticals.
APEIRON Biologics
APEIRON Biologics
APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies.
OxThera
OxThera
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
KBP Biosciences
KBP Biosciences
KBP is developing a pipeline of new chemical entities with known mechanisms of action in areas of unmet medical need in cardiovascular, infectious disease, respiratory, inflammatory and autoimmune diseases.
Abivax
Abivax
Abivax is a biotech company that mobilizes the body’s natural immune system to treat patients suffering from inflammatory diseases, infectious diseases, and cancer.
Siege Pharmaceuticals
Siege Pharmaceuticals
Siege Pharmaceuticals is a company engaged in developing cancer treatment.
Founding Date
Founding Date
2005
Founding Date
N/A
Founding Date
2007
Founding Date
2013
Founding Date
2018
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Wien, AT HQ
Locations
Stockholm, SE HQ
Knoxville, US
Locations
Princeton, US HQ
Jinan Shi, CN
Locations
Paris, FR HQ
Montpellier, FR
Locations
Irvine, US HQ
Employees
Employees
19
Employees
109% decrease
Employees
383% increase
Employees
264% increase
Employees
2
Twitter followers
Twitter followers
680
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.3 k
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
184726
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
623873
Alexa Website Rank
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
4
Employee Rating
N/A
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
kr11m (FY, 2015)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
(kr37.8m) (FY, 2015)
Net income
N/A
Net income
(€41.4m) (FY, 2021)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 53.3m
Total funding raised
$ 76m
Total funding raised
$ 13.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

OxThera
HQ
Stockholm, SE
Employees
10↓ 9% decrease

OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.

View company
KBP Biosciences
HQ
Princeton, US
Employees
38↑ 3% increase

KBP is developing a pipeline of new chemical entities with known mechanisms of action in areas of unmet medical need in cardiovascular, infectious disease, respiratory, inflammatory and autoimmune diseases.

View company
Abivax
HQ
Paris, FR
Employees
26↑ 4% increase

Abivax is a biotech company that mobilizes the body’s natural immune system to treat patients suffering from inflammatory diseases, infectious diseases, and cancer.

View company
Siege Pharmaceuticals
HQ
Irvine, US
Employees
2

Siege Pharmaceuticals is a company engaged in developing cancer treatment.

View company